1 The pharmacokinetics and haemodynamic effects of nisoldipine on long term i.v. infusion of 2.40 mg and 9.59 mg in 25 h were studied in six healthy subjects. Liver blood flow at 0.8 and 24 h was assessed by measuring indocyanine green (ICG) clearance.2 After high-dose nisoldipine, systemic clearance was 0.99 ± 0.16 1 min-', volume of distribution was 5.8 ± 1.5 1 kg-' and elimination half-life was 10.7 ± 2.4 h. The pharmacokinetic parameters were similar after low-dose nisoldipine. 3 No significant changes in apparent liver blood flow were observed after either highdose or low-dose nisoldipine. 4 Systolic blood pressure did not change, whereas diastolic blood pressure decreased by approximately 10% during both treatments. Maximal increase in heart rate was approximately 37% at high-dose infusion, whereas this was one half lower during the low-dose regimen. 5 Increased infusion rate results in an unfavourable shift in the haemodynamic effect profile of nisoldipine.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.